Amniotic Membrane Market Analysis & Forecast: 2025-2032

Amniotic Membrane Market is estimated to be valued at USD 4.62 Bn in 2025 and is expected to reach USD 10.87 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 13% from 2025 to 2032.

Analysts’ Views on Global Amniotic Membrane Market:

The amniotic membrane (AM), or amnion, is a thin membrane on the inner side of the fetal placenta; it completely surrounds the embryo and delimits the amniotic cavity, which is filled with amniotic liquid. The rising number of patients with ophthalmology diseases, orthopedic diseases, and surgeries are expected to increase the probability of physicians preferring amniotic membranes for treatment. Thus, it offers the opportunity for various manufacturers to offer innovative amniotic membraine products that allow surgeons to perform such surgeries more efficiently.

Figure 1. Global Amniotic Membrane Market Share (%), By Product Type, 2025

To learn more about this report, Request sample copy

Global Amniotic Membrane Market– Drivers

Increasing Product Launches by the Market Players

On July 26, 2022, Eliksa Therapeutics, a regenerative medicine company, aimed to commercialize multiple regenerative therapeutics based on amniotic fluid and amniotic membrane technologies.

Increasing Research and Development Activities by the Market Players

On September 16, 2022, Théa Pharma Inc., an independent pharmaceutical company, showcased AcellFX, an acellular amniotic membrane, at Vision Expo West.

Figure 2. Global Amniotic Membrane Market Share (%), By Region, 2025

To learn more about this report, Request sample copy

Global Amniotic Membrane Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global amniotic membrane market over the forecast period. North America is estimated to hold 36%  of the market share in 2025. The global amniotic membrane market is expected to witness significant growth in the coming years, driven by increasing inorganic strategies by market players. For instance, on November 3, 2022, InfuSystem Holdings, Inc., a healthcare company that provides infusion pumps, and Sanara MedTech Inc., a medical technology company, announced the establishment of a partnership, SI Wound Care, LLC, focused on delivering a complete wound care solution targeted at improving patient outcomes and lowering the cost of care.

Global Amniotic Membrane Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, faced problems with the transportation of things from one place to another.

However, the COVID-19 pandemic had a negative impact on the global amniotic membrane market, owing to widespread lockdowns, elective procedures being cancelled or postponed, and wound care treatments not being provided. In order to reserve or reallocate the limited capacities and resources (such as hospital beds and patient care specialists) towards COVID-19 patient care, elective procedures were being refused (cancelled or postponed). Additionally, many nations implemented curfews and lockdowns to stop the growth in COVID-19 instances. Patients were unable to visit clinics, hospitals, or OPDs as a result of these lockdowns. The expansion of the market for amniotic products is anticipated to be constrained by this temporary denial of non-emergent healthcare services. However, in the upcoming years, it is anticipated that demand for amniotic membrane products would increase.

Global Amniotic Membrane Market Segmentation:

The global amniotic membrane market report is segmented by product type, by application, by end user, and by region.

• By product type, the market is segmented into amniotic membranes (cryopreserved amniotic membranes, dehydrated amniotic membranes) and amniotic suspensions. Out of which, the amniotic membranes (cryopreserved amniotic membranes, dehydrated amniotic membranes) are expected to hold a dominant position in the global amniotic membrane market during the forecast period, and this is attributed to technological advancement.
• By application, the market is segmented into wound care, orthopedics, ophthalmology, and others. Out of which, ophthalmology is expected to dominate the market over the forecast period, and this is attributed to increasing ophthalmology diseases globally.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutes. Out of which, hospital is expected to dominate the market over the forecast period, and this is attributed to the prompt treatment that can lead to proper recovery.

Among all the segmentation, the application segment is expected to dominate the market over the forecast period, and this is attributed to the increasing prevalence of ophthalmology disease and surgeries globally.

Global Amniotic Membrane Market- Cross Sectional Analysis:

Key players are focusing on organic strategies to increase their footprint in the market, which is expected propel market growth over the forecast period. For instance, on February 28, 2020, Integra LifeSciences, a medical device company, launched the AmnioExcel Plus Placental Allograft Membrane. This product, launched under the company’s wound care portfolio, is designed to aid in the repair of soft tissue.

Global Amniotic Membrane Market: Key Developments

• On September 13, 2021, MiMedx Group, Inc., a biomedical company, reported data from two late-stage musculoskeletal trials with proprietary amniotic tissue technology.
• On May 19, 2021, VIVEX Biologics, Inc., a regenerative medicine company, announced the launch of  VIAGENEX, a family of amniotic allografts processed to retain the inherent mechanical properties of amniotic tissue and a rich supply of extracellular matrix, growth factors, and cytokines.

Global Amniotic Membrane Market: Key Trends

• Increasing Research and Developmental Activities for the Development of Novel Product: Increasing research and development activities for the development of new products is expected to propel market growth over the forecast period. For instance, on March 8, 2021, Amniox Medical, Inc., a clinical application of human birth tissue-based products company, announced that the company had received clearance from the U.S. Food and Drug Administration (FDA) to proceed with the dosing study using its investigational new drug (IND) TTAX03 to treat facet joint pain resulting from osteoarthritis (OA).

Global Amniotic Membrane Market: Restraint

• The market player are not obliged to the U.S. FDA regulation : The market players are not manufacturing products with U.S. FDA guidelines, which is expected to hinder market growth over the forecast period. For instance, on October 26, 2022, Vitti Labs, LLC, a regenerative product manufacturing company, received a warning letter from the Food and Drug Administration (FDA) for amniotic membrane products.

Market players should follow the regulatory guidelines to develop the products.

Global Amniotic Membrane Market - Key Players

Major players operating in the global amniotic membrane market include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical

Global Amniotic Membrane Market– Definition

The innermost layer of the fetal membrane, known as the amniotic membrane, is removed from women's placentas and harvested for use as transplant material in reconstructive surgery for conditions like severely burned skin, trauma wounds, chronic wounds, and others.